Levin Capital Strategies, LP recently stated that they own 25.2% of Fluidigm Corp. (NASDAQ:FLDM) in a Schedule 13D disclosure that was filed with the Securities and Exchange Commission (SEC) on Friday, October 14th. The investor owns 7,317,390 shares of the stock valued at approximately $32,708,733. The reporting parties listed on the disclosure included Levin Capital Strategies, LP, Levin Capital Strategies GP, LLC, Levin Capital Trilogy Master Fund, Ltd, Lcs, LLC, Levcap Alternative Fund, LP, LCS Event Partners, LLC, Safinia Partners, LP, Lcs L/S, LLC and John A Levin. The filing is available through Edgar at this link.
Several other hedge funds have also recently made changes to their positions in the stock. Levin Capital Strategies L.P. increased its stake in shares of Fluidigm Corp. by 72.0% in the second quarter. Levin Capital Strategies L.P. now owns 3,595,575 shares of the company’s stock valued at $32,468,000 after buying an additional 1,505,320 shares during the last quarter. Emerald Acquisition Ltd. purchased a new stake in shares of Fluidigm Corp. during the second quarter valued at approximately $13,020,000. Wellington Management Group LLP increased its stake in shares of Fluidigm Corp. by 28.6% in the first quarter. Wellington Management Group LLP now owns 961,070 shares of the company’s stock valued at $7,756,000 after buying an additional 213,670 shares during the last quarter. Ghost Tree Capital LLC purchased a new stake in shares of Fluidigm Corp. during the second quarter valued at approximately $1,355,000. Finally, Dimensional Fund Advisors LP increased its stake in shares of Fluidigm Corp. by 740.1% in the second quarter. Dimensional Fund Advisors LP now owns 134,871 shares of the company’s stock worth $1,218,000 after buying an additional 118,816 shares in the last quarter. Hedge funds and other institutional investors own 93.33% of the company’s stock.
Shares of Fluidigm Corp. (NASDAQ:FLDM) traded down 3.97% during trading on Friday, hitting $4.47. 675,411 shares of the company’s stock were exchanged. The company’s market cap is $129.79 million. Fluidigm Corp. has a 12-month low of $4.41 and a 12-month high of $12.09. The company has a 50-day moving average of $8.26 and a 200-day moving average of $9.13.
Fluidigm Corp. (NASDAQ:FLDM) last announced its quarterly earnings results on Thursday, August 4th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.58) by $0.06. Fluidigm Corp. had a negative return on equity of 45.68% and a negative net margin of 52.04%. The firm had revenue of $28.20 million for the quarter, compared to analysts’ expectations of $29.62 million. During the same period last year, the company posted ($0.53) earnings per share. The business’s quarterly revenue was down 1.5% on a year-over-year basis. On average, equities analysts expect that Fluidigm Corp. will post ($2.32) earnings per share for the current fiscal year.
A number of analysts have issued reports on the stock. Cantor Fitzgerald reduced their price target on shares of Fluidigm Corp. from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Friday, August 5th. Mizuho lifted their price target on shares of Fluidigm Corp. from $11.00 to $12.00 and gave the company a “buy” rating in a report on Friday, August 5th. Finally, Zacks Investment Research downgraded shares of Fluidigm Corp. from a “buy” rating to a “hold” rating in a report on Monday, July 11th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Fluidigm Corp. has a consensus rating of “Buy” and a consensus target price of $13.76.
About Fluidigm Corp.
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
Want to see what other hedge funds are holding FLDM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fluidigm Corp. (NASDAQ:FLDM).
Receive News & Ratings for Fluidigm Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corp. and related companies with MarketBeat.com's FREE daily email newsletter.